
The molnupiravir pill is cleared for use by adults 18 and older who have tested positive for COVID-19 and are at high risk of being hospitalized or dying.
The FDA on Wednesday authorized Pfizer's paxlovin drug. Both pills may be taken orally at home, giving health care providers another tool to prevent severe disease amid a wave of omicron variant infections.